
The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Fibroblast growth factor 2 's neighborhood in the knowledge graph.
N-{3-{[(beta-D-glucopyranosyl)uronic acid]-(1->3)-(2-acetamido-2-deoxy-4,6-di-O-sulfo-beta-D-galactopyranosyl)-(1->4)-[(beta-D-glucopyranosyl)uronic acid]-(1->3)-(2-acetamido-2-deoxy-4-O-sulfo-beta-D-galactopyranosyl)-(1->6)-(1-deoxy-D-glucitol-1-yl)amino}phenyl}-DL-alpha-lipoamide trisodium bioactivity Fibroblast growth factor 2
Knowledge Graph Assertion (Entity type)A Knowledge Graph Assertion from IDG
3-Stearamidopropyl 2,3,4,6-tetra-O-sulfo-alpha-D-mannopyranosyl-(1->3)-2,4,6-tri-Osulfo-alpha-D-mannopyranosyl-(1->3)-2,4,6-tri-O-sulfo-alpha-D-mannopyranosyl-(1->2)-3,4,6-tri-O-sulfo-alpha-D-mannopyranoside, tridecasodium salt bioactivity Fibroblast growth factor 2
Knowledge Graph Assertion (Entity type)A Knowledge Graph Assertion from IDG
8-(4-Phenyl[1,2,3]triazol-1-yl)octyl 2,3,4,6-Tetra-O-sulfo-alpha-D-mannopyranosyl-(1->3)-2,4,6-tri-O-sulfo-alpha-D-mannopyranosyl-(1->3)-2,4,6-tri-O-sulfo-alpha-D-mannopyranosyl-(1->3)-2,4,6-tri-O-sulfo-alpha-D-mannopyranosyl-(1->2)-3,4,6-tri-O-sulfo-alpha-D-mannopyranoside,Hexadecasodium Salt bioactivity Fibroblast growth factor 2
Knowledge Graph Assertion (Entity type)A Knowledge Graph Assertion from IDG
A Knowledge Graph Assertion from IDG
A Knowledge Graph Assertion from IDG
decasodium[(2R,3R,4S,5R,6R)-2-[(2R,3R,4S,5R,6R)-6-[(2R,3R,4S,5R,6R)-6-[[(3S,5S,8R,9S,10S,13R,14S,17R)-17-[(1R)-1,5-dimethylhexyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfonatooxy-2-(sulfonatooxymethyl)tetrahydropyran-3-yl]oxy-4,5-disulfonatooxy-2-(sulfonatooxymethyl)tetrahydropyran-3-yl]oxy-3,5-disulfonatooxy-6-(sulfonatooxymethyl)tetrahydropyran-4-yl]sulfate bioactivity Fibroblast growth factor 2
Knowledge Graph Assertion (Entity type)A Knowledge Graph Assertion from IDG
6-{5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazolidin-4-yl]pentanamido}-N-[(2S,3S,4S,5S,6R)-3-{[(2R,3S,4S,5R,6R)-4-{[(2R,3S,4S,5R,6R)-4-{[(2R,3S,4S,5R,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-{[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]hexanamide bioactivity Fibroblast growth factor 2
Knowledge Graph Assertion (Entity type)A Knowledge Graph Assertion from IDG
A Knowledge Graph Assertion from IDG
3-(4-Phenyl[1,2,3]triazol-1-yl)propyl 2,3,4,6-Tetra-O-sulfo-alpha-D-mannopyranosyl-(1->3)-2,4,6-tri-O-sulfo-alpha-D-mannopyranosyl-(1->3)-2,4,6-tri-O-sulfo-alpha-D-mannopyranosyl-(1->2)-3,4,6-tri-O-sulfo-alpha-D-mannopyranoside, Tridecasodium Salt bioactivity Fibroblast growth factor 2
Knowledge Graph Assertion (Entity type)A Knowledge Graph Assertion from IDG